Orbit CEO Neil Butt and Business Developer Simon Bushell will be the 2024 BioEurope conference in Stockholm, Sweden from November 4-6th, 2024. They would be delighted to talk about how our platforms empower big pharma and small biotech alike in their peptide discovery efforts.
Orbit CEO, Neil Butt will be attending the 2024 European Association for Nuclear Medicine Congress in Hamburg, Germany from October 19th to 23rd. Come learn more about how Orbit is helping leading radiopharmaceutical companies discover novel peptide conjugates for radionuclide delivery.
Simon Bushell, will be attending the 37th European Peptide Symposium, to be held in August in Florence, Italy. This year the event is merged with the 14th International Peptide Symposium, and promises to be the biggest peptide event of the year.